Robuta

https://www.businesswire.com/news/home/20251204684749/en/Seaport-Therapeutics-to-Present-at-2025-RBC-Capital-Markets-Healthcare-Private-Company-Conference?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw%3D%3D

https://www.biospace.com/press-releases/seaport-therapeutics-presents-new-meta-analysis-examining-correlations-between-clinical-trial-design-factors-and-placebo-response-in-major-depressive-disorder-studies